✦ LIBER ✦

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

✍ Scribed by Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugiura; Kazuhide Makiyama; Noboru Nakaigawa; Takeshi Kishida; Takehiko Ogawa; Masahiro Yao; Yoshinobu Kubota

Publisher: Springer
Year: 2005
Tongue: English
Weight: 210 KB
Volume: 10
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-005-0490-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent docetaxel therapy with estr

Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Clinical research on treatment of advanc

Clinical research on treatment of advanced androgen independent prostate cancer with Docetaxel and Thalidomide

✍ Jing Tian; Donghai Teng; Xiangdong Shu; Hong Lu; Hui Chen; Peng Guo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 73 KB

Multimodality treatment in hormone-refra

Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Bernard A. Zonnenberg 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 75 KB

A phase II trial of docetaxel and vinore

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

✍ Susan Goodin; Kamakshi V. Rao; Michael Kane; Nisha Dave; Terry Capanna; Susan Do 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Treatment of androgen-independent prosta

Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental study

✍ Jeffrey F. Williams; Heather J. Muenchen; Jeffrey M. Kamradt; Susan Korenchuk; K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi